References
Sanders, C. C.: Novel resistance selected by the new expanded-spectrum cephalosporins: a concern. Journal of Infectious Diseases 1983, 147: 585–589.
Cullmann, W., Dalhoff, A., Dick. W.: Specific and unspecific induction ofβ-lactamases. In: Proceedings of the 13th International Congress of Chemotherapy, Vienna, 1983.
Dalhoff, A.: Interaction of mezlocillin and cefoxitin againstProteus morganii in the granuloma pouch model. European Journal of Clinical Microbiology 1982, 1: 243–247.
Cullmann, W., Opferkuch, W., Stieglitz, M., Dick, W.: Antibakterielle Aktivität neuerβ-Laktamantibiotika in Abhängigkeit von derβ-Laktamasebildung. Fortschritte der Antimikrobiellen Chemotherapie 1983, 2: 253–259.
Jones, R. N., Wilson, H. W., Novick, W. J., Barry, A. L., Thornsberry, C.: In vitro evaluation of CentaR, a new beta-lactamase susceptible chromogenic cephalosporin reagent. Journal of Clinical Microbiology 1982, 15: 954–958.
Markwell, M. A. K., Hass, S. M., Bieber, L. L., Tolbert, N. E.: A modification of the Lowry procedure to simplify protein determinations in membranes and lipoprotein samples. Analytical Biochemistry 1978, 87: 206–210.
Then, R. L.: Properties of Ro 13-9904 as a substrate and inhibitor ofβ-lactamases. Chemotherapy 1981, 27, Supplement 1: 25–31.
Dick, W., Cullmann, W.: The interaction of beta-lactam compounds with chromosomally mediated enzymes: relations to the molecular structure. In: Proceedings of the 13th International Congress of Chemotherapy, Vienna, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cullmann, W., Opferkuch, W. & Stieglitz, M. Relation between beta-lactamase production and antimicrobial activity: Comparison of the new compound HR 810 with cefotaxime. Eur. J, Clin. Microbiol. 2, 350–352 (1983). https://doi.org/10.1007/BF02019466
Issue Date:
DOI: https://doi.org/10.1007/BF02019466